SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI
SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI
SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/us/spl/ValueSet/valueset-splMarketingCategories | Version: 0.2.1 | |||
| Standards status: Trial-use | Maturity Level: 1 | Computable Name: SPLMarketingCategories | ||
Codes from NCI Thesaurus for SPL Marketing Categories (C43164 Subset)
References
Generated Narrative: ValueSet valueset-splMarketingCategories
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl| Code | Display |
| C101533 | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| C117717 | Master File |
| C132333 | Approved Drug Product Manufactured Under Contract |
| C132334 | OTC Monograph Drug Product Manufactured Under Contract |
| C132335 | Unapproved Drug Product Manufactured Under Contract |
| C175238 | Multi-Market Approved Product |
| C175462 | SIP Approved Drug |
| C181659 | Outsourcing Facility Compounded Human Drug Product (Exempt From Approval Requirements) |
| C190698 | Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed) |
| C200263 | OTC Monograph Drug |
| C73583 | ANADA |
| C73584 | ANDA |
| C73585 | BLA |
| C73586 | BULK ACTIVE INGREDIENT |
| C73587 | BULK INACTIVE INGREDIENT |
| C73588 | CONDITIONAL NADA |
| C73590 | EXPORT ONLY |
| C73593 | NADA |
| C73594 | NDA |
| C73605 | NDA AUTHORIZED GENERIC |
| C73613 | UNAPPROVED MEDICAL GAS |
| C73614 | UNAPPROVED HOMEOPATHIC |
| C73615 | UNAPPROVED VITAMIN DRUG |
| C73626 | BULK INGREDIENT |
| C73627 | UNAPPROVED DRUG OTHER MARKETING CATEGORY |
| C75302 | IND |
| C80438 | EXEMPT DEVICE |
| C80440 | HUMANITARIAN DEVICE EXEMPTION |
| C80441 | PREMARKET APPLICATION |
| C80442 | PREMARKET NOTIFICATION |
| C86952 | DIETARY SUPPLEMENT |
| C86964 | MEDICAL FOOD |
| C86965 | COSMETIC |
| C92556 | LEGALLY MARKETED UNAPPROVED NEW ANIMAL DRUGS FOR MINOR SPECIES |
| C94795 | DRUG FOR FURTHER PROCESSING |
| C95600 | APPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR |
| C95601 | OTC MONOGRAPH DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR |
| C95602 | UNAPPROVED DRUG PRODUCT MANUFACTURED EXCLUSIVELY FOR PRIVATE LABEL DISTRIBUTOR |
| C96793 | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| C96794 | BULK INGREDIENT FOR ANIMAL PRESCRIPTION COMPOUNDING |
| C96966 | Emergency Use Authorization |
| C98252 | BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING |
Generated Narrative: ValueSet
This value set contains 42 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2020+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.spl#0.2.1 based on FHIR 5.0.0. Generated 2024-12-10
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change